(AACE 2017) American association of clinical endocrinologists and american college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease.Endocrine practice Vol 23 (Suppl 2) April 2017




(2016) Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

Interazioni tra le varie statine ed altri farmaci per il sistema cardiovascolare frequentemente utilizzati in associazione. Lo statement dell’American Heart Association




(2016) European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk

Documento di consenso sull’utilizzo degli inibitori del PCSK9 nel trattamento dell’ipercolesterolemia della Società Europea di Cardiologia e della Società Europea dell’Aterosclerosi




2016 ESC/EAS Guidelines for the management of dyslipidaemias




(2016) Colesterolo e rischio cardiovascolare: percorso diagnostico-terapeutico in Italia. Documento di consenso intersocietario ANMCO/ISS/AMD/ANCE/ARCA/FADOI/ GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/ SID/SIF/SIMEU/SIMG/SIMI/SISA




2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk




2015 USDA. Scientific Report Dietary Guidelines Advisory Committee




NICE 2014. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease




2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk




(2008) NICE. Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease




(2013) Linee guida ACC/AHA sul trattamento dell’ipercolesterolemia per ridurre il rischio cardiovascolare nell’adulto (versione inglese)




(2012) Linee guida ESC (società europea di cardiologia) sulla gestione delle dislipidemie (versione inglese)